Note every animal. Quoting https://link.springer.com/article/10.1007/s11357-020-00274-1:
] Although the overwhelming majority of studies on the effect of rapamycin on longevity in mice have shown a significant increase in lifespan, there are five studies that have reported either no effect or reduced lifespan when treated with rapamycin.
When you write "every animal it is given" .. do you mean only flies and mice?
I've been having a hard time finding results for any other animals.
There's a decade of research with marmosets (here's a 2012 mention about it in Nature - https://www.nature.com/articles/492S18a ), but none of the papers I find report lifespan, only secondary measures (eg, "Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets" - https://onlinelibrary.wiley.com/doi/10.1002/ajp.22927 ).
Since marmosets live for about 15 to 16 years, surely there should be something concrete by now if it has the same effect on middle-aged marmosets when the research started.
I found there's research for dogs, but https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507265/ says it's also ongoing. I haven't found any published results on lifespan only, again, on secondary effects (eg, quoting the paper, "An initial randomized, double-blind veterinary clinical trial confirmed the safety of this treatment and provided indications of potential efficacy (benefits for cardiac function) in dogs".)
What other animals have shown improved lifespan with rapamycin?
If it's only flies and (most) mice, is that really enough to call it "promising" in humans?